BioHarvest SciencesBHST -1.42%63 Days Inventory is 125.30 as of Mar. 2026, which is 21% above its 10-year median of 103.25. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.57 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,865 Consumer Packaged Goods companies, BioHarvest Sciences ranks worse than 66.49% on this metric.
The historical rank and industry rank for BioHarvest Sciences's Days Inventory or its related term are showing as below:
BHST'
s Days Inventory Range Over the Past 10 Years
Min: 98.35 Med: 103.25 Max: 141.47
Current: 113.33
During the past 12 years, BioHarvest Sciences's highest Days Inventory was 141.47. The lowest was 98.35. And the median was 103.25.
BHST's Days Inventory is ranked worse than 66.49% of 1865
companies
in the Consumer Packaged Goods industry
Industry Median: 82.85
vs BHST: 113.33
BioHarvest Sciences's Days Inventory
increased
from Mar. 2025 (107.14) to Mar. 2026 (125.30).
It might indicate that BioHarvest Sciences's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BioHarvest Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.73.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioHarvest Sciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.56.
BioHarvest Sciences (NAS:BHST) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioHarvest Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioHarvest Sciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BioHarvest Sciences Days Inventory Related Terms
BioHarvest Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for BioHarvest Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BHST vs BRID, BOF, BFNH: Days Inventory Comparison
For the Packaged Foods subindustry, BioHarvest Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences Days Inventory vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioHarvest Sciences (BHST) has a Days Inventory of 125.30 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioHarvest Sciences and its competitors. This is 21% above median its historical median of 103.25. Over the past decade, BioHarvest Sciences' Days Inventory has ranged from 98.35 to 141.47. According to the industry distribution chart, BioHarvest Sciences ranks #1240 out of 1865 companies in the Consumer Packaged Goods industry, placing it in the top 66.5%.
Is BioHarvest Sciences' Days Inventory too high?
BioHarvest Sciences' current Days Inventory of 125.30 is 21% above median its 10-year median of 103.25. Over the past 10 years, this metric has ranged from a low of 98.35 to a high of 141.47. The Consumer Packaged Goods industry median Days Inventory is 82.85. BioHarvest Sciences' value of 125.30 is 51.2% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #1240 out of 1865 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Days Inventory compare to BRID and BOF?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #1240 out of 1865 companies for Days Inventory. This places BioHarvest Sciences in the lower half of its industry. The industry median Days Inventory is 82.85. BioHarvest Sciences' value of 125.30 is 51.2% above this benchmark. Historically, BioHarvest Sciences' own Days Inventory has ranged from 98.35 to 141.47 over the past decade. While the company's 10-year median is 103.25 vs. the industry median of 82.85, BioHarvest Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 82.85, based on 1,865 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current Days Inventory of 125.30 is 51.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 82.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current Days Inventory is 125.30, which is 21% above median its own 10-year median of 103.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.57, compared to a current price of $2.77 — trading 67.7% below its estimated fair value. The current Days Inventory is 125.30, which is 21% above median its 10-year median of 103.25 and 51.2% above the Consumer Packaged Goods industry median of 82.85. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Days Inventory is 125.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioHarvest Sciences (BHST) Overvalued in 2026?
Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued.
The current stock price of $2.77 is trading 67.7% below its estimated GF Value™ of $8.57.
GuruFocus considers BioHarvest Sciences to be Possible Value Trap.
Key valuation signals for BHST:
Days Inventory: 125.30 (21% above median its 10-year median of 103.25)
GF Value™: $8.57 vs. price of $2.77 (67.7% below fair value)
Industry Position: 51.2% above the Consumer Packaged Goods median (#1240 of 1865)
No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score
Get the complete analysis for BHST
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHST has been successfully added to your 
